News
Important Only
Other
Hubbell's quarterly profit rises on strong data center product demand
Feb 3 (Reuters) - Hubbell HUBB.N posted a rise in fourth-quarter profit on Tuesday, helped by strong demand for its electrical equipment from data centers. Shelton, Connecticut-based Hubbell, whose products include wiring and lighting systems, has benefited from the global rise in data center constr...Reuters
Tue, Feb 3
Forex
Pepsico Affirms 2026 Financial Outlook
Feb 3 (Reuters) - PepsiCo Inc PEP.O:PEPSICO Q4 CORE EPS $2.26 VERSUS IBES ESTIMATE $2.24PEPSICO Q4 NET REVENUE $29.34 BILLION VERSUS IBES ESTIMATE $28.97 BILLIONPEPSICO Q4 ORGANIC REVENUE GROWTH 2.1%PEPSICO: AFFIRMS 2026 FINANCIAL OUTLOOKPEPSICO: 4% INCREASE IN ANNUALIZED DIVIDEND TO $5.92 PER SHARE...Reuters
Tue, Feb 3
Economic Indicator
WRAPUP 2-Trump's tariff cut sparks relief in India despite scant details
Trump cuts tariffs on Indian goods to 18% from 50%India to raise U.S. oil, defence goods, aircraft purchasesDeal lifts India markets; broader trade talks to followIndian refiners need time to stop Russian oil importsBy Shivangi Acharya and Manoj Kumar NEW DELHI, Feb 3 (Reuters) - U.S. President ...Reuters
Tue, Feb 3
Other
Sanofi - Rezurock Now Reimbursed In Ontario And British Columbia For People Living With Chronic Graft-Versus-Host Disease (Gvhd)
Feb 3 (Reuters) - Sanofi SA SASY.PA:SANOFI - REZUROCK NOW REIMBURSED IN ONTARIO AND BRITISH COLUMBIA FOR PEOPLE LIVING WITH CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)Reuters
Tue, Feb 3
Stocks
Aluminum can maker Ball Corp beats fourth-quarter estimates on strong demand
Feb 3 (Reuters) - Aluminum packaging company Ball Corp BALL.N beat analysts' estimate for fourth-quarter sales and profit on Tuesday, helped by strong demand for its recyclable cups and bottles from consumer goods makers.Ball Corp, which supplies packaging to major food and beverage companies ac...Reuters
Tue, Feb 3
Other
Kratos Wins Aviation System, Warfighter Contract Awards Worth Up To $65 Million
Feb 3 (Reuters) - Kratos Defense and Security Solutions Inc KTOS.O:KRATOS RECENTLY RECEIVED AVIATION SYSTEM AND RELATED WARFIGHTER CONTRACT AWARDS WITH TOTAL POTENTIAL VALUE OF APPROXIMATELY $65 MILLIONKRATOS DEFENSE AND SECURITY SOLUTIONS INC - CONTRACTS INCLUDE AWARDS FROM U.S. DEPARTMENT OF WAR A...Reuters
Tue, Feb 3
Cryptocurrencies
Coinbase Accuses Australian Banks of Unlawful Regulatory Ban as Maxi Doge Pumps
Tensions are boiling over Down Under. Coinbase has formally accused major Australian banks of imposing a shadow ban on the industry. Executives argue that banks are systematically restricting transfers to crypto platforms, effectively ‘de-banking’ users without a clear mandate. That opac...Bitcoinist
Tue, Feb 3
Other
Olympics-Curling-Team US bring 'the calm and the fire' to mixed doubles competition
CORTINA D'AMPEZZO, Feb 3 (Reuters) - American curlers Korey Dropkin and Cory Thiesse may be polar opposites on the ice, but they feel their contrasting personalities could create the perfect mix as they head into the mixed doubles competition at the Milano Cortina Winter Olympics.The pair, world...Reuters
Tue, Feb 3
Cryptocurrencies
Best Crypto to Buy Now: Why Bitcoin Hyper Is Standing Out as Markets Pause
The crypto market has entered one of those phases that rarely make headlines but often shape what comes next. Price action across major assets has slowed, volatility has compressed, and even Bitcoin is struggling to establish a clear short-term direction. For many investors, this environment raises ...NewsBTC
Tue, Feb 3
Other
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer
Feb 3 (Reuters) - GSK plc GSK.L:GSK - QUEBEC TO REIMBURSE JEMPERLI PLUS CHEMOTHERAPY VIA RAMQ FOR TREATMENT OF PATIENTS WITH PRIMARY ADVANCED/FIRST RECURRENT ENDOMETRIAL CANCERReuters
Tue, Feb 3
Other
Relay Therapeutics Announces Zovegalisib Granted Therapy Designation By FDA For Pik3ca-Mutant
Feb 3 (Reuters) - Relay Therapeutics Inc RLAY.O:RELAY THERAPEUTICS ANNOUNCES ZOVEGALISIB GRANTED BREAKTHROUGH THERAPY DESIGNATION BY U.S. FDA FOR PIK3CA-MUTANT, HR+/HER2- ADVANCED BREAST CANCERReuters
Tue, Feb 3
Other
Trump-backed deal to end shutdown faces tight House vote
By David Morgan WASHINGTON, Feb 3 (Reuters) - The Republican-controlled U.S. House of Representatives will try to pass a deal that would end the latest government shutdown on Tuesday over opposition from an unusual alignment of Democrats and hardline conservatives.The legislation would fund defen...Reuters
Tue, Feb 3
Other
Replimune's Q3 net loss widens as R&D expenses rise
OverviewBiotechnology firm's fiscal Q3 net loss was $70.9 mln vs $66.3 mln a year agoCompany preparing for RP1 launch, pending FDA approvalLoan agreement amended to extend cash runway into Q1 2027OutlookReplimune expects FDA decision on RP1 by April 10, 2026Company extends cash runway into Q1 20...Reuters
Tue, Feb 3
Commodities
REFILE-China to expand its copper strategic reserve, industry association says
Feb 3 (Reuters) - China will expand its copper strategic reserve, an official from the state-backed China Nonferrous Metals Industry Association said on Tuesday.The remarks were made by Duan Shaofu, the deputy secretary-general of the association, at a press conference, according to Shanghai Securit...Reuters
Tue, Feb 3
Other
Morris State Bancshares Q4 profit rises as NIM improves
OverviewGeorgia bank's Q4 net income decreased from Q3 but increased from Q4 2024Company declared increased quarterly dividend and special dividendCompany received regulatory approval for merger with Vallant FinancialOutlookCompany anticipates completing merger with Vallant Financial by March 20...Reuters
Tue, Feb 3
Other
Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia)
Feb 3 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRAGENYX ANNOUNCES POSITIVE LONGER-TERM DATA DEMONSTRATING TREATMENT WITH UX111 GENE THERAPY RESULTS IN SUSTAINED, SIGNIFICANT REDUCTIONS IN CSF-HS AND CONTINUED MEANINGFUL IMPROVEMENTS IN CLINICAL FUNCTION ACROSS MULTIPLE DEVELOPMENTAL DOMAIN...Reuters
Tue, Feb 3
